Isabelle Maridonneau‐Parini

Université Toulouse III - Paul Sabatier — France

Immunology and Microbiology · Life Sciences

55h-index8.7kcitations201works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(35), Cellular Mechanics and Interactions(25), Click Chemistry and Applications(22), HIV Research and Treatment(19), Cell Adhesion Molecules Research(19)

Publications199 total

Moesin controls cell–cell fusion and osteoclast function
The Journal of Cell Biology·2025· 5 citedOpen Access
Ezrin, radixin, and moesin are dispensable for macrophage migration and cellular cortex mechanics
The EMBO Journal·2024· 6 citedOpen Access
Moesin controls cell-cell fusion and osteoclast function
2024· 2 citedOpen Access
Author Reply to Peer Reviews of The membrane-actin linkers ezrin, radixin, and moesin are dispensable for macrophage migration and cortex mechanics.
2023
The membrane-actin linkers ezrin, radixin, and moesin are dispensable for macrophage migration and cortex mechanics
2023· 4 citedOpen Access
Supplemental Table 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Video 5 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Supplemental figure 2 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Video 4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Video 5 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Video 4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Video 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Supplementary Fig S4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Supplemental figure 3 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Supplementary Fig S4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Video 3 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Supplementary Data from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Data from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Supplemental figure 3 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
Video 2 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Véronique Le Cabec(17), Renaud Poincloux(15), Céline Cougoule(12), Christel Vérollet(8), Geanncarlo Lugo‐Villarino(7), Olivier Neyrolles(6), Shanti Souriant(6), Talal Al Saati(6), Romain Guiet(5), Guillaume M. Charrière(5), Catherine Astarie‐Dequeker(5), Claire Lastrucci(5), Karine Pingris(5), Arnaud Labrousse(5), Emeline Van Goethem(4), Elsa-Noah N’Diaye(4), Stéphanie Balor(4), Christophe Thibault(4), Maeva Dupont(4), Luciana Balboa(4)